Demo
AI-Enhanced Monitoring: Assessing Clinical Quality of Subjective Data
Mon, Sep 29, 2025 · 4:15–4:45 PM EDT Room 339+340, Baltimore Convention Center
About this session
How artificial intelligence is revolutionizing data quality assurance for subjective clinical endpoints that make or break regulatory submissions
The Problem: Clinical trials rely heavily on subjective assessments (MMSE, ADAS-Cog, MDRAS) for primary endpoints, but traditional quality review methods leave 80-90% of these critical assessments unchecked due to resource constraints.
The Solution: Our AI-enhanced review system analyzes 100% of assessment recordings, automatically flagging potential administration and scoring issues for targeted intervention.
